Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fungal and yeast surface antigens represent a heterogeneous collection of molecules, primarily located within the complex cell wall, that serve as the primary interface between the fungal pathogen and the host immune system (Erwig & Gow, 2016). These antigens include essential structural components such as (1,3)-beta-D-glucan, chitin, and various mannoproteins, which are critical for maintaining cell wall integrity and mediating adhesion to host tissues (Brown, 2006). In the context of infectious diseases, these surface molecules are recognized by pattern recognition receptors (PRRs) on host immune cells, such as Dectin-1, triggering inflammatory responses and phagocytosis (Erwig & Gow, 2016). Therapeutically, these antigens are targeted by several classes of antifungal agents; for instance, the echinocandin class (e.g., caspofungin) specifically inhibits the synthesis of beta-glucan, leading to osmotic instability and cell death (Denning, 2003). Additionally, surface antigens serve as critical diagnostic biomarkers, such as the galactomannan assay used for detecting invasive aspergillosis, and are active areas of research for the development of monoclonal antibodies and vaccines aimed at enhancing the host's ability to clear fungal infections (Maertens et al., 2005; Perfect, 2017).
Inhibition of (1,3)-beta-D-glucan synthase; antibody-mediated opsonization and phagocytosis; disruption of cell wall structural integrity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fungal and yeast surface antigens.